Clover Health Investments Q3 Sales $482.07M Miss $494.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Clover Health Investments (NASDAQ:CLOV) reported Q3 sales of $482.07 million, missing the analyst consensus estimate of $494.60 million by 2.53 percent. This represents a 43.74 percent decrease compared to the same period last year.
November 06, 2023 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Clover Health's Q3 sales fell short of estimates and decreased significantly YoY, which could negatively impact its stock price.
Clover Health's Q3 sales not only missed analyst estimates but also showed a significant decrease compared to the same period last year. This underperformance could lead to a negative sentiment among investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100